Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 35 of 59, showing 10 Applications out of 584 total, starting on record 341, ending on 350

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

341.

ECCT/20/09/01   PrEP in Pharmacy - PILOT STUDY
    Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot study       
Principal Investigator(s)
1. Kenneth Kairu Ngure
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
28-10-2020 View

342.

ECCT/20/09/04   Pharmacy PrEP Delivery
    Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot Study   
Principal Investigator(s)
1. Prof. Elizabeth Bukusi
Site(s) in Kenya
1. PHRDTHIKA (Kiambu county)
2. Kisumu Site (Kisumu county)
 
27-10-2020 View

343.

ECCT/20/06/08   E-MOTIVE TRIAL
    Early detection of PPH and treatment using the WHO MOTIVE ‘first response’ bundle: a cluster randomised trial with health economic analysis and mixed-methods evaluation.           
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Mwingi Sub county (level 4 ) hospital (Kitui county)
2. Nyeri Level 5 Hospital (Nyeri county)
3. Garissa county referral hospital (Garissa county)
4. Embu Level 5 hospital (Embu county)
5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county)
6. Meru Teaching and Referral Hospital (Meru county)
7. Kitengela Sub county Hospital (Kajiado county)
8. Kakamega County Government Referral Hospital (Kakamega county)
9. Mbagathi County Hospital (Nairobi City county)
10. St. Mary\'s Mission Hospital (Nairobi City county)
 
19-10-2020 View

344.

ECCT/20/06/07   Quality of Oxytocin and TXA
    Quality of Oxytocin and Tranexamic acid in selected facilities in six countries   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Mwingi Sub county (level 4 ) hospital (Kitui county)
2. Nyeri Level 5 Hospital (Nyeri county)
3. Garissa county referral hospital (Garissa county)
4. Embu Level 5 hospital (Embu county)
5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county)
6. Meru Teaching and Referral Hospital (Meru county)
7. Kitengela Sub county Hospital (Kajiado county)
8. Mbagathi County Hospital (Nairobi City county)
9. Kakamega County Government Referral Hospital (Kakamega county)
10. St. Mary\'s Mission Hospital (Nairobi City county)
 
19-10-2020 View

345.

ECCT/20/07/02   RV 460 HIV Vaccine Trial
    A Randomized, Double-Blind Phase 1 Trial to Evaluate the Safety and Immunogenicity of   Priming with Env-C Plasmid DNA Vaccine Alone, with Different Adjuvants, or with an   Adjuvanted HIV Env gp145 C.6980 Protein Vaccine and Boosting with the Adjuvanted   HIV Env gp145 C.6980 Protein Vaccine with or without the Env-C Plasmid DNA Vaccine   in Healthy HIV Uninfected Adults in Kenya   
Principal Investigator(s)
1. Josphat Kosgei
Site(s) in Kenya
KEMRI/US MRDA-A/K, KERICHO
 
19-10-2020 View

346.

ECCT/20/06/06   E-MOTIVE FORMATIVE
    Understanding effectiveness of implementation of a postpartum haemorrhage initial response bundle   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Mwingi Sub county (level 4 ) hospital (Kitui county)
2. Nyeri Level 5 Hospital (Nyeri county)
3. Garissa county referral hospital (Garissa county)
4. Embu Level 5 hospital (Embu county)
5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county)
6. Meru Teaching and Referral Hospital (Meru county)
7. Kitengela Sub county Hospital (Kajiado county)
8. Kakamega County Government Referral Hospital (Kakamega county)
9. Mbagathi County Hospital (Nairobi City county)
10. St. Mary\'s Mission Hospital (Nairobi City county)
 
15-10-2020 View

347.

ECCT/20/07/01   Convalescent plasma trial
    A randomized control trial comparing convalescent plasma therapy plus standard treatment versus standard treatment alone in patients with severe COVID-19 pneumonia at a tertiary hospital   
Principal Investigator(s)
1. Dr Isaac Adembesa Kadambi
Site(s) in Kenya
Kenyatta University Teaching Referral and Research Hospital
 
25-09-2020 View

348.

ECCT/20/06/04   ANTICOV (01 COV)
    An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild /moderate cases of COVID-19   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Mbagathi Infectious Disease Hospital (Nairobi City county)
2. Kenyatta University Teaching, Referral and Research Hospital (Nairobi City county)
 
18-09-2020 View

349.

ECCT/20/06/09   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa   
Principal Investigator(s)
1. Professor Walter Jaoko, Jaoko,
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. KEMRI/ Wellcome Trust Research Programme (Kilifi county)
 
09-09-2020 View

350.

ECCT/20/05/01   ChAdOx1 nCoV-19 trial
    A phase Ib/II single-blinded, randomised, controlled study to determine safety, immunogenicity and efficacy of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in adults in Kenya   
Principal Investigator(s)
1. George Warimwe
Site(s) in Kenya
KEMRI-CGMRC
 
08-09-2020 View